Write For Us

COVAXIN's efficacy is 50 percent against Coronavirus' Delta variant

Sponsored Post Vitamin D2 Canada Persia
51 Views
Published
The first real world data of Bharat Biotech's corona vaccine has revealed that the COVAXIN has an efficacy of 50 percent against the Delta variant of Coronavirus. The details have been published in the medical journal, The Lancet. This real world study was done at Delhi's AIIMS Hospital. As per the researchers, the study was done when the second wave was at its peak and the case positivity was very high.
Category
Asia
Tags
abp news live, abp live, abp news
Sign in or sign up to post comments.
Be the first to comment